7PLUS Coin— Medical Textile with New Innovation Drydye Technology

What is the 7PLUS Coin about?

7PLUS COIN is developed to enhance and promote seamless transactions between the Yeh Group of companies and tens of hundreds of future medical establishments worldwide. Such establishments ranges from reputable pharma companies like US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney/Dechra, Clinipace Worldwide and many others.

7PLUS Coin is an ERC-20 utility token that is built on the Ethereum blockchain. It has a total supply of 200 million tokens, and to be at $0.1 per SV7 coin during private and public sale respectively.

About Yeh Group

Yeh Group is Penn Asia’s parent company with paid up capital of 500 million Baht a warp and weft knitting business with its dyeing and finishing. The company is located in Thailand, the heart of Southeast Asia, only 35 km west of Bangkok. Yeh Group manufactures functional fabrics (intimate apparel and sportswear) for the global market. The company manufactures mainly nylon and spandex yarns, although polyester with spandex is gaining ground as they serve as rigid fabrics. Yeh Group has been working in partnership with notable regional brands in underwear and sports for more than 25 years.

Penn Asia has about 350 employees, while Yeh Group has approximately 1000 employees. Owing to the outbreak of the COVID-19 pandemic, Yeh Group has given more attention to the production of novel, highly protective textile materials with biological and chemical protection. This included their innovation of new drydye dying and printing microfiber face masks for medical and daily use.


Medical textile supplies belong to a wide range of materials heavily regulated due to their safety implications. These textile supplies are typically used in the operating theater or hospital wards for staff and patients’ hygiene and safety. They are either washable or disposable. Examples of these medical supplies include surgical gowns, caps, masks, patient drapes, and cover clothes for various sizes. The medical textile supplies used in hospital wards include bedding, clothing, mattresses, covers, and wipes.

Problems & Solutions

1. Poor healthcare and pharmaceutical supply chain management and tracking

This was a huge problem during the coronavirus pandemic heat. Government agencies found it very difficult to track the volumes and locations of essential supplies. It had a devastating impact on curbing the spread of the virus and protecting the population.


A blockchain-enabled supply chain allows immutable, transparent, and efficient tracking of medical supply from its production point down to the consumer. Across the supply chain, the blockchain helps to provide information, transparency, proof, accuracy. with such information, supply chain associated risks will be at its minimum for all parties; manufacturers and consumers inclusive.

2. Lack of confidence and Public panic

When it was discovered that the face masks from China to Europe (UK, China, Ireland, etc.) were contaminated, it spread panic among the population. Public panic will do more harm than good as we try to tackle the outbreak of this pandemic.


A blockchain system that securely tracks and proves the ingredients, production volumes, availability, and quality will significantly improve public confidence in the materials and even drugs. The blockchain system will enable fact-based information sharing. Tracing the origin and endpoints of medical textile material will reduce unnecessary exposure and legal risks.

3. Lack of ease of payment

Traditionally, cross border payments come with high banking fees and time delays due to physical distance. This has really not helped the fight to combat the spread of the coronavirus pandemic. The delay in processing transactions stalls the transportation of medical textile materials on time to places they are needed. Also, large multinational companies find it difficult to keep track of numerous business deals and accounts financially.


To solve the lack of ease of payment in the supply chain of COVID-19 medical supply kits, one can adopt a digital asset payment system to make it easy for both manufacturers and buyers. A good example of such digital assets is the 7PLUS COIN being created by the Yeh Group of companies.

4. Counterfeit products

The counterfeit drug market is worth a staggering $75 billion annually, including medical textile supplies. On July 24, 2020, INTERPOL reported global seizures of falsified medical products related to Covid-19. The seized items include 34,000 counterfeit and substandard face masks. At a time when standard medical textile supplies are essential, we can’t afford to allow the proliferation of counterfeits into the global market.


With the decentralized and immutable record features that blockchain offers, we can track every COVID-19 textile medical supplies journey to verify its authenticity or the lack thereof.


Yeh Group has made tremendous progress in the development of efficient and effective textile medical supplies. Yeh Group currently develops protective clothing for medical staff, field workers, etc. Yeh Microfiber facemask medical products and daily wear is designed with our dry dye technology. They deliver 99% filtration efficiency and are very comfortable to wear. Yeh masks have higher breathability than N95 masks and other non-woven masks.


Yeh Group employs special Drydye waterless technology for the production of its medical textile covid-19 materials. Only 6 manufacturing companies in the world use the DryDye technology. Still, Yeh Group is the only one with a one stop service from yarn spinning, weaving, waterless dyeing, and printing with advanced drydye to avoid water pollution. Aside from the advanced drydye technology, Yeh Group also uses blockchain technology in its supply chain process to enable more transparent and accurate end-to-end tracking of medical textile products. The blockchain protocol allows retailers to verify all covid-19 medical kits’ authenticity coming from the Yeh Group


Sevenplus has paid its token holders in dividends, reaching an annualized dividend yield of 15%.

benefit in two parts — bonus comes from token sale and the other 15% from annualized dividend yield.

7plus Coin (SYMBOL:SV7) Token Allocation

7PLUS COIN is developed to enhance and promote seamless transactions between the Yeh Group of companies and tens of hundreds of future medical establishments worldwide. Such establishments ranges from reputable pharma companies like US WorldMeds, Elorac Inc., Pacira Pharmaceuticals, Inc., Putney/Dechra, Clinipace Worldwide and many others. 7PLUS Coin is an ERC-20 utility token that is built on the Ethereum blockchain. It has a total supply of 200 million token, and to be at $0.1 per SV7 coin during private and public sale respectively.

7plus Token Sale

The token sale will be in batches and will take place along with some marketing auctions. It will follow a two round token sale offering period to allow investors at various stages contribute to the token sale. The total supply token is 200,000,000, and the price per token is $0.1. The total fund expected to be raised is $20 million. The first sale will be held from February 12, 2021 to February 28, 2021. Those who buy within this period will receive a 25% bonus on their purchase. The second phase of sale will hold between April 1, 2021 to May 31, 2021. People who purchase within the first two weeks of sale will receive 15% bonus. If you buy within 3-4 weeks of sale, you will receive a 10% bonus. Also, those that purchase within 5-8 weeks will receive a bonus of 5%. All sales will end on May 31, 2021. After the soft cap or hard cap is reached, live trading will go public on Bitenium Exchange on June 1, 2021.

Pre Sale

Pre Sale will start Fri, 12 Feb 2021 07:00 (GMT+7)


●  Total sell: 0.0000 (0.00%) SV7

●  Softcap period: 16 Days

●  Hardcap period: 60 Days

●  Today: 0 SV7

●  Total ETH: 0.0000 ETH

●  Softcap: 20,000,000 SV7


●  Name: 7PLUS COIN (SV7)

●  Date: Fri, 12 Feb 2021 07:00 (GMT+7)

●  Price: 1 SV7 = 0.10 USD

●  Homepage: https://7pluscoin.com

●  Bonus: 0%

●  Softcap: 20,000,000

●  Bonus Lockup Hardcap: 180,000,000

●  Tech: ERC-20


Investors stand to drive varieties of utility and savings from the 7PLUS COIN token ; Which will give a high yield with 15% return per annum. Investors can benefit with the utility token to purchase their all textile including undergarments, sportswear and medical textile products will be allocated and distributed through our channels and partners including retail outlets and online shopping. Moreover , promotions will be implaced with special membership rewards and discounted prices.

Just invest in 7PLUS COIN and enjoy the return is much greater with and expected yield of 15% net per annum which will be given on a monthly payout plan. This will be paid directly into their wallet through 7PLUS COIN, and they can cash out with multiple exchanges.

The funds received from investors will be used and applied towards the payout our debts. By having good cash flow, we will be able to develop and expand more machineries which will further enhance the supply chain related software and increase its efficiency. Hence, this will allow us to have complete traceability of all our products with our associated brand partners and distribution channels including all outlets in Thailand and international market. We will buy back 20% of our tokens for the next two years and burn the coins. The remain of 60% coins will be circulating in multiple exchanges.



Introducing and launch of 7PLUS Brand to the domestic and international market. Authentic token and native L2L token based on economic model development on ERC20

Feb. 2021:

Official project announcement. Release of white paper and multiple social media platforms. Open to public for Presale, Private sale and soft cap through IEO on Bitenium exchange.

Apr. – May 2021:

7PLUS open the public through retail outlets and e-commerce. Start and offer of hard cap and distribution of 7PLUSCOIN to investors

Q4 2021:

List in Coinmarketcap.com. 7PLUSCOIN open for public trading on Bitenium exchange. Develop supply chain software for our Drydye and medical textile and more international 7PLUS retail outlet.

Q1 2022:

Road show and introduction of the expertise team behind 7PLUS. Display the newest solution and benefits of sportswear, undergarments and medical textile with Drydye technology.

Q3 2022:

Q3 2023 Buy back and burn 20% of 7PLUSCOIN. Total buy back will be 40%. Remaining tokens will be circulating in the exchange market.

Our Team

Jimmy Yeh – President

Chareeporn Yeh – Vice President

Negel Page – CMO Sales & Marketing

Prathya Thanasomboon – CPO Administrative

Sorin Mic – Operation Director

David Round – Innovation Director

X 10 Agency – Bounty, Marketing&Community Management


Medical Advisor


Blockchain Consultant Advisor

Dusit Madan

Kanjana Wattanavichean

Chanin Torut

●  Website: https://7pluscoin.com/

●   Facebook: https://www.facebook.com/SV7PlusCoin-103483088392823

●  Telegram: https://t.me/English7plus

●  Twitter:  https://twitter.com/7pluscoin

●  Youtube: https://www.youtube.com/channel/UCqqoJ6ai6yLzmcFw_ZxUfJw

●  Medium: https://seventhcoin7.medium.com/


Bitcointalk Username: martin688

Bitcointalk Profile link: https://bitcointalk.org/index.php?action=profile;u=1723324

Telegram Username: @martin160388

ETH Wallet address : 0xc34C03eB6bB9dDC7286dB1670fAC7f6c3c0902E1


Leave a Comment